Home

CHANE GRAZIANO

CIK 1133234 · Chief Executive Officer · last filed 2013-11-07

CHANE GRAZIANO is a Chief Executive Officer who has filed 14 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for HBIO, was dated Nov 7, 2013. Across all open-market trades the lifetime net is +$494.7K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.8M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.78M

Companies

2

Total Filings

14

Lifetime Open-Market Net

$494.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HBIO Chief Executive Officer 300,515 $5.92 $1.78M $494.7K 13 2013-11-07
Harvard Apparatus Regenerative Technology, Inc. (HART) Delisted 10%+ Owner 676,287 $30.67 $20.74M $0 1 2013-11-07

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-11-07 HBIO Gift (G) −100,000 $0 EDGAR
2013-11-07 Harvard Apparatus Regenerative Technology, Inc. (HART) Delisted Gift (G) −100,000 $0 EDGAR
2013-08-29 HBIO Buy (P) +60,000 $300.0K EDGAR
2013-07-31 HBIO Mixed +437,707 -$359.0K EDGAR
2012-12-13 HBIO Exer (M) +200,000 $696.0K EDGAR
2012-06-04 HBIO Grant (A) +105,042 $0 EDGAR
2011-06-07 HBIO Grant (A) +53,750 $0 EDGAR
2011-01-26 HBIO Tax (F) −11,353 -$46.3K EDGAR
2010-09-16 HBIO Buy (P) +100,000 $358.1K EDGAR
2010-09-16 HBIO Buy (P) −44,732 -$163.3K EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.